{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:51:56Z","timestamp":1783338716625,"version":"3.54.6"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-025-01706-2","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T09:21:58Z","timestamp":1756200118000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bilateral, multicystic fumarate hydratase-deficient renal cell carcinoma in patient with hereditary leiomyomatosis & renal cell carcinoma syndrome: A case report and review of the literature"],"prefix":"10.1186","volume":"20","author":[{"given":"Ashlie","family":"E Rubrecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"H Aldrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"T. Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Moulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilay","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"issue":"2","key":"1706_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ucl.2023.01.010","volume":"50","author":"O Iliopoulos","year":"2023","unstructured":"Iliopoulos O. Diseases of hereditary renal cell cancers. Urol Clin North Am. 2023;50(2):205\u201315.","journal-title":"Urol Clin North Am"},{"key":"1706_CR2","unstructured":"Hes O, Gill AJ, Gupta S, Jimenez RE, Smith SC, Trpkov K. Fumarate hydratase-deficient renal cell carcinoma. 2022. In: Urinary and Male Genital Tumours [Internet]. Lyon, France: International Agency for Research on Cancer. 5th. WHO classification of tumours series. Available from: https:\/\/tumourclassification.iarc.who.int\/chaptercontent\/36\/9"},{"issue":"15","key":"1706_CR3","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1128\/MCB.00483-09","volume":"29","author":"S Sudarshan","year":"2009","unstructured":"Sudarshan S, Sourbier C, Kong HS, Block K, Valera Romero VA, Yang Y, et al. Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species. Mol Cell Biol. 2009;29(15):4080\u201390.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"1706_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ccr.2005.06.017","volume":"8","author":"JS Isaacs","year":"2005","unstructured":"Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL, et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell. 2005;8(2):143\u201353.","journal-title":"Cancer Cell"},{"key":"1706_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.semcdb.2019.05.002","volume":"98","author":"C Schmidt","year":"2020","unstructured":"Schmidt C, Sciacovelli M, Frezza C. Fumarate hydratase in cancer: A multifaceted tumour suppressor. Semin Cell Dev Biol. 2020;98:15\u201325.","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"1706_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cancergencyto.2009.08.018","volume":"196","author":"Y Yang","year":"2010","unstructured":"Yang Y, Valera VA, Padilla-Nash HM, Sourbier C, Vocke CD, Vira MA, et al. UOK 262 cell line, fumarate hydratase deficient (FH-\/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer. Cancer Genet Cytogenet. 2010;196(1):45\u201355.","journal-title":"Cancer Genet Cytogenet"},{"issue":"5","key":"1706_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2340\/0001555553409416","volume":"53","author":"WB Reed","year":"1973","unstructured":"Reed WB, Walker R, Horowitz R. Cutaneous leiomyomata with uterine leiomyomata. Acta Derm Venereol. 1973;53(5):409\u201316.","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"1706_CR8","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1073\/pnas.051633798","volume":"98","author":"V Launonen","year":"2001","unstructured":"Launonen V, Vierimaa O, Kiuru M, Isola J, Roth S, Pukkala E, et al. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A. 2001;98(6):3387\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1706_CR9","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ng849","volume":"30","author":"IP Tomlinson","year":"2002","unstructured":"Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet. 2002;30(4):406\u201310.","journal-title":"Nat Genet"},{"issue":"4","key":"1706_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/jmg.2010.085068","volume":"48","author":"B Gardie","year":"2011","unstructured":"Gardie B, Remenieras A, Kattygnarath D, Bombled J, Lef\u00e8vre S, Perrier-Trudova V, et al. Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma. J Med Genet. 2011;48(4):226\u201334.","journal-title":"J Med Genet"},{"issue":"1","key":"1706_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1086\/376435","volume":"73","author":"JR Toro","year":"2003","unstructured":"Toro JR, Nickerson ML, Wei MH, Warren MB, Glenn GM, Turner ML, et al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet. 2003;73(1):95\u2013106.","journal-title":"Am J Hum Genet"},{"key":"1706_CR12","doi-asserted-by":"crossref","unstructured":"Sanchez-Heras AB, Castillejo A, Garcia-Diaz JD, Robledo M, Teule A, Sanchez R et al. Hereditary leiomyomatosis and renal cell cancer syndrome in spain: clinical and genetic characterization. Cancers (Basel). 2020;12(11).","DOI":"10.3390\/cancers12113277"},{"issue":"11","key":"1706_CR13","doi-asserted-by":"publisher","first-page":"100303","DOI":"10.1016\/j.modpat.2023.100303","volume":"36","author":"L Zheng","year":"2023","unstructured":"Zheng L, Zhang X, Pan X, Huang Z, Zhang M, Xian J, et al. AKR1B10 is a new sensitive and specific marker for fumarate Hydratase-Deficient renal cell carcinoma. Mod Pathol. 2023;36(11):100303.","journal-title":"Mod Pathol"},{"issue":"1","key":"1706_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1399-0004.2010.01486.x","volume":"79","author":"DL Smit","year":"2011","unstructured":"Smit DL, Mensenkamp AR, Badeloe S, Breuning MH, Simon ME, van Spaendonck KY, et al. Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis. Clin Genet. 2011;79(1):49\u201359.","journal-title":"Clin Genet"},{"issue":"6","key":"1706_CR15","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.euo.2019.11.002","volume":"3","author":"C Forde","year":"2020","unstructured":"Forde C, Lim DHK, Alwan Y, Burghel G, Butland L, Cleaver R, et al. Hereditary leiomyomatosis and renal cell cancer: clinical, molecular, and screening features in a cohort of 185 affected individuals. Eur Urol Oncol. 2020;3(6):764\u201372.","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"1706_CR16","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/gcc.22452","volume":"56","author":"CD Vocke","year":"2017","unstructured":"Vocke CD, Ricketts CJ, Merino MJ, Srinivasan R, Metwalli AR, Middelton LA, et al. Comprehensive genomic and phenotypic characterization of germline FH deletion in hereditary leiomyomatosis and renal cell carcinoma. Genes Chromosomes Cancer. 2017;56(6):484\u201392.","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"1706_CR17","doi-asserted-by":"publisher","first-page":"E2046","DOI":"10.1210\/jc.2014-1659","volume":"99","author":"GR Clark","year":"2014","unstructured":"Clark GR, Sciacovelli M, Gaude E, Walsh DM, Kirby G, Simpson MA, et al. Germline FH mutations presenting with pheochromocytoma. J Clin Endocrinol Metab. 2014;99(10):E2046\u201350.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1706_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1159\/000445430","volume":"232","author":"E Guinard","year":"2016","unstructured":"Guinard E, Legendre L, Kramkimel N, Avril MF, Chassaing N, Cabaret O, et al. Complete penetrance and absence of intrafamilial variability in a large family with hereditary leiomyomatosis and renal cell carcinoma. Dermatology. 2016;232(3):293\u20137.","journal-title":"Dermatology"},{"issue":"3","key":"1706_CR19","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0002-9440(10)61757-9","volume":"159","author":"M Kiuru","year":"2001","unstructured":"Kiuru M, Launonen V, Hietala M, Aittom\u00e4ki K, Vierimaa O, Salovaara R, et al. Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. Am J Pathol. 2001;159(3):825\u20139.","journal-title":"Am J Pathol"},{"issue":"10","key":"1706_CR20","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","volume":"31","author":"MJ Merino","year":"2007","unstructured":"Merino MJ, Torres-Cabala C, Pinto P, Linehan WM. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol. 2007;31(10):1578\u201385.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"1706_CR21","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/s41379-018-0017-7","volume":"31","author":"M Muller","year":"2018","unstructured":"Muller M, Guillaud-Bataille M, Salleron J, Genestie C, Deveaux S, Slama A, et al. Pattern multiplicity and fumarate hydratase (FH)\/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alteration. Mod Pathol. 2018;31(6):974\u201383.","journal-title":"Mod Pathol"},{"issue":"1","key":"1706_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13023-020-01653-9","volume":"16","author":"Z Chayed","year":"2021","unstructured":"Chayed Z, Kristensen LK, Ousager LB, R\u00f8nlund K, Bygum A. Hereditary leiomyomatosis and renal cell carcinoma: a case series and literature review. Orphanet J Rare Dis. 2021;16(1):34.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1706_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10689-011-9485-3","volume":"11","author":"VM Raymond","year":"2012","unstructured":"Raymond VM, Herron CM, Giordano TJ, Gruber SB. Familial renal cancer as an indicator of hereditary leiomyomatosis and renal cell cancer syndrome. Fam Cancer. 2012;11(1):115\u201321.","journal-title":"Fam Cancer"},{"issue":"5","key":"1706_CR24","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","volume":"38","author":"YB Chen","year":"2014","unstructured":"Chen YB, Brannon AR, Toubaji A, Dudas ME, Won HH, Al-Ahmadie HA, et al. Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry. Am J Surg Pathol. 2014;38(5):627\u201337.","journal-title":"Am J Surg Pathol"},{"key":"1706_CR25","unstructured":"Network NCC. Kidney Cancer 2025 [Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/kidney.pdf"},{"issue":"1","key":"1706_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jaad.2017.01.023","volume":"77","author":"VM Patel","year":"2017","unstructured":"Patel VM, Handler MZ, Schwartz RA, Lambert WC. Hereditary leiomyomatosis and renal cell cancer syndrome: an update and review. J Am Acad Dermatol. 2017;77(1):149\u201358.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1706_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10689-019-00155-3","volume":"19","author":"JA Hol","year":"2020","unstructured":"Hol JA, Jongmans MCJ, Littooij AS, de Krijger RR, Kuiper RP, van Harssel JJT, et al. Renal cell carcinoma in young FH mutation carriers: case series and review of the literature. Fam Cancer. 2020;19(1):55\u201363.","journal-title":"Fam Cancer"},{"issue":"1","key":"1706_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/PAS.0000000000001372","volume":"44","author":"HD Lau","year":"2020","unstructured":"Lau HD, Chan E, Fan AC, Kunder CA, Williamson SR, Zhou M, et al. A clinicopathologic and molecular analysis of fumarate Hydratase-deficient renal cell carcinoma in 32 patients. Am J Surg Pathol. 2020;44(1):98\u2013110.","journal-title":"Am J Surg Pathol"},{"issue":"7\u20138","key":"1706_CR29","doi-asserted-by":"publisher","first-page":"E214","DOI":"10.5489\/cuaj.3798","volume":"10","author":"JB Lattouf","year":"2016","unstructured":"Lattouf JB, Pautler SE, Reaume MN, Kim RH, Care M, Green J, et al. Structured assessment and followup for patients with hereditary kidney tumour syndromes. Can Urol Assoc J. 2016;10(7\u20138):E214\u201322.","journal-title":"Can Urol Assoc J"},{"key":"1706_CR30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2147\/IJNRD.S42097","volume":"7","author":"LS Schmidt","year":"2014","unstructured":"Schmidt LS, Linehan WM. Hereditary leiomyomatosis and renal cell carcinoma. Int J Nephrol Renovasc Dis. 2014;7:253\u201360.","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"4","key":"1706_CR31","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10689-014-9735-2","volume":"13","author":"FH Menko","year":"2014","unstructured":"Menko FH, Maher ER, Schmidt LS, Middelton LA, Aittomaki K, Tomlinson I, et al. Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment. Fam Cancer. 2014;13(4):637\u201344.","journal-title":"Fam Cancer"},{"issue":"2","key":"1706_CR32","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10689-011-9428-z","volume":"10","author":"HJ Lehtonen","year":"2011","unstructured":"Lehtonen HJ. Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics. Fam Cancer. 2011;10(2):397\u2013411.","journal-title":"Fam Cancer"},{"issue":"1","key":"1706_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2350-9-20","volume":"9","author":"J-P Bayley","year":"2008","unstructured":"Bayley J-P, Launonen V, Tomlinson IP. The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency. BMC Med Genet. 2008;9(1):20.","journal-title":"BMC Med Genet"},{"issue":"3","key":"1706_CR34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10689-021-00268-8","volume":"21","author":"R Taniguchi","year":"2022","unstructured":"Taniguchi R, Muramatsu H, Okuno Y, Yoshida T, Wakamatsu M, Hamada M, et al. A patient with very early onset FH-deficient renal cell carcinoma diagnosed at age seven. Fam Cancer. 2022;21(3):337\u201341.","journal-title":"Fam Cancer"},{"issue":"1","key":"1706_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/his.13183","volume":"71","author":"SC Smith","year":"2017","unstructured":"Smith SC, Sirohi D, Ohe C, McHugh JB, Hornick JL, Kalariya J, et al. A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma. Histopathology. 2017;71(1):42\u201352.","journal-title":"Histopathology"},{"issue":"4","key":"1706_CR36","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/his.13395","volume":"72","author":"Y Li","year":"2018","unstructured":"Li Y, Reuter VE, Matoso A, Netto GJ, Epstein JI, Argani P. Re-evaluation of 33 \u2018unclassified\u2019 eosinophilic renal cell carcinomas in young patients. Histopathology. 2018;72(4):588\u2013600.","journal-title":"Histopathology"},{"issue":"7","key":"1706_CR37","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/PAS.0000000000000617","volume":"40","author":"K Trpkov","year":"2016","unstructured":"Trpkov K, Hes O, Agaimy A, Bonert M, Martinek P, Magi-Galluzzi C, et al. Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome. Am J Surg Pathol. 2016;40(7):865\u201375.","journal-title":"Am J Surg Pathol"},{"key":"1706_CR38","doi-asserted-by":"publisher","first-page":"151599","DOI":"10.1016\/j.anndiagpath.2020.151599","volume":"49","author":"N Kuroda","year":"2020","unstructured":"Kuroda N, Tsutsui M, Iguchi M, Nobuoka E, Uehara T, Sonobe Y, et al. Fumarate hydratase-deficient renal cell carcinoma: A clinicopathological study of seven cases including hereditary and sporadic forms. Ann Diagn Pathol. 2020;49:151599.","journal-title":"Ann Diagn Pathol"},{"key":"1706_CR39","doi-asserted-by":"crossref","unstructured":"Teh J, Kinnear N, Douglass-Molloy H, Hennessey DB. Hereditary leiomyomatosis and renal cell cancer syndrome: a family affair. BMJ Case Rep. 2017;2017.","DOI":"10.1136\/bcr-2016-218270"},{"issue":"11","key":"1706_CR40","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1097\/PAS.0000000000000719","volume":"40","author":"SC Smith","year":"2016","unstructured":"Smith SC, Trpkov K, Chen YB, Mehra R, Sirohi D, Ohe C, et al. Tubulocystic carcinoma of the kidney with poorly differentiated foci: A frequent morphologic pattern of fumarate Hydratase-deficient renal cell carcinoma. Am J Surg Pathol. 2016;40(11):1457\u201372.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"1706_CR41","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.humpath.2006.10.011","volume":"38","author":"HJ Lehtonen","year":"2007","unstructured":"Lehtonen HJ, Blanco I, Piulats JM, Herva R, Launonen V, Aaltonen LA. Conventional renal cancer in a patient with fumarate hydratase mutation. Hum Pathol. 2007;38(5):793\u20136.","journal-title":"Hum Pathol"},{"issue":"3","key":"1706_CR42","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1365-2133.2008.09000.x","volume":"160","author":"S Badeloe","year":"2009","unstructured":"Badeloe S, van Spaendonck-Zwarts KY, van Steensel MA, van Marion AM, van Essen AJ, Jonkman MF, et al. Wilms tumour as a possible early manifestation of hereditary leiomyomatosis and renal cell cancer? Br J Dermatol. 2009;160(3):707\u20139.","journal-title":"Br J Dermatol"},{"issue":"6","key":"1706_CR43","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1136\/jmg.2005.036400","volume":"43","author":"HJ Lehtonen","year":"2006","unstructured":"Lehtonen HJ, Kiuru M, Ylisaukko-Oja SK, Salovaara R, Herva R, Koivisto PA, et al. Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet. 2006;43(6):523\u20136.","journal-title":"J Med Genet"},{"issue":"4","key":"1706_CR44","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ccr.2007.02.005","volume":"11","author":"PJ Pollard","year":"2007","unstructured":"Pollard PJ, Spencer-Dene B, Shukla D, Howarth K, Nye E, El-Bahrawy M, et al. Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway. Cancer Cell. 2007;11(4):311\u20139.","journal-title":"Cancer Cell"},{"issue":"1","key":"1706_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2133.2005.06678.x","volume":"153","author":"NA Alam","year":"2005","unstructured":"Alam NA, Olpin S, Leigh IM. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer. Br J Dermatol. 2005;153(1):11\u20137.","journal-title":"Br J Dermatol"},{"key":"1706_CR46","first-page":"303872","volume":"2015","author":"BT Ristau","year":"2015","unstructured":"Ristau BT, Kamat SN, Tarin TV. Abnormal cystic tumor in a patient with hereditary leiomyomatosis and renal cell cancer syndrome: evidence of a precursor lesion?? Case Rep Urol. 2015;2015:303872.","journal-title":"Case Rep Urol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01706-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-025-01706-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01706-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:52:32Z","timestamp":1757443952000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-025-01706-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1706"],"URL":"https:\/\/doi.org\/10.1186\/s13000-025-01706-2","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethics approval required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from the patient\/family.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}